NCT02136888View on ClinicalTrials.gov

Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Healthy
Interventions
DRUG

Ponesimod Placebo

DRUG

Moxifloxacin Placebo

DRUG

Ponesimod 10 mg

DRUG

Ponesimod 20 mg

DRUG

Ponesimod 40 mg

DRUG

Ponesimod 60 mg

DRUG

Ponesimod 80 mg

DRUG

Ponesimod 100 mg

DRUG

Moxifloxacin 400 mg

Trial Locations (1)

47710

Covance Clinical Research Unit (CRU), Evansville

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT02136888 - Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter